Drugs / CAR-NK cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05247957 | Oct 2021 → Dec 2022 | — | Hangzhou Cheetah Cell Therapeutics Co., Ltd | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-NK cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05247957 ↗ |
| Modality | Cell therapy | “cord blood NKG2D CAR-NK” NCT05247957 ↗ |